Table 1. Demographic characteristics of patients and technical aspects of enteroscopies performed for SSBB (overt and occult) compared with NSBB

Values are presented as number (%) or median (interquartile range) unless otherwise defined.

SB, small bowel; SSBB, suspected SB bleeding; NSSB, non-SB bleeding.

Table 2. Demographic characteristics of patients and technical aspects of enteroscopies performed for SSBB in patients receiving antithrombotic therapies compared with SSBB population

Values are presented as number (%) or median (interquartile range) unless otherwise defined.

DOAC, direct oral anticoagulant; VKA, vitamin K antagonist; APA, antiplatelet agent; SSBB, suspected small bowel bleeding; Pt, no. of patients recieving the drug; ASA, acetylsalicylic acid; DAPT, dual antiplatelet therapy; DY, diagnostic yield.

a)

SSBB vs. DOAC,

b)

SSBB vs. VKA,

c)

SSBB vs. APA,

d)

DOAC vs. VKA,

e)

DOAC vs. APA,

f)

VKA vs. APA.

Table 3. Videocapsule endoscopic findings in DOAC, VKA, and APA

Values are presented as number (%).

DOAC, direct oral anticoagulant; VKA, vitamin K antagonist; APA, antiplatelet agent.

a)

DOAC vs. VKA,

b)

DOAC vs. APA,

c)

VKA vs. APA.

Table 4. Demographic characteristics of patients and technical aspects of videocapsule endoscopy and their findings in patients receiving anticoagulants and/or antiplatelet therapies as mono- or combined therapy

Values are presented as number (%) or median (interquartile range) unless otherwise defined.

Table 5. Suspected small bowel bleeding pattern according to the variety of antithrombotic drugs

Values are presented as number (%).

APA, antiplatelet agent.

a)

Anticoagulated vs. APAs,

b)

anticoagulated vs. no therapy,

c)

APAs vs. no therapy,

d)

anticoagulated+APAs vs. no therapy.

Table 6. Suspected small bowel bleeding pattern according to the number of antithrombotic drugs

Values are presented as number (%).